List of Excipients in API neomycin and polymyxin b sulfates and hydrocortisone otic
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing neomycin and polymyxin b sulfates and hydrocortisone otic
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION | neomycin and polymyxin b sulfates and hydrocortisone otic | 50090-6336 | CETYL ALCOHOL | |
| A-S Medication Solutions | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION | neomycin and polymyxin b sulfates and hydrocortisone otic | 50090-6336 | POLYSORBATE 80 | |
| A-S Medication Solutions | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION | neomycin and polymyxin b sulfates and hydrocortisone otic | 50090-6336 | PROPYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for neomycin and polymyxin b sulfates and hydrocortisone otic
Excipient focus: CETYL ALCOHOL
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants containing CETYL ALCOHOL
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants containing POLYSORBATE 80
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants containing PROPYLENE GLYCOL
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants containing SULFURIC ACID
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: THIMEROSAL
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants containing THIMEROSAL
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants not containing THIMEROSAL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants containing WATER
neomycin and polymyxin b sulfates and hydrocortisone otic drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
